BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27176741)

  • 1. Insights into K-Ras 4B regulation by post-translational lysine acetylation.
    Knyphausen P; Lang F; Baldus L; Extra A; Lammers M
    Biol Chem; 2016 Oct; 397(10):1071-85. PubMed ID: 27176741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric Regulation of Switch-II Domain Controls KRAS Oncogenicity.
    Yang MH; Tran TH; Hunt B; Agnor R; Johnson CW; Shui B; Waybright TJ; Nowak JA; Stephen AG; Simanshu DK; Haigis KM
    Cancer Res; 2023 Oct; 83(19):3176-3183. PubMed ID: 37556505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation.
    Yin G; Kistler S; George SD; Kuhlmann N; Garvey L; Huynh M; Bagni RK; Lammers M; Der CJ; Campbell SL
    J Biol Chem; 2017 Mar; 292(11):4446-4456. PubMed ID: 28154176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring Ras Interactions with the Nucleotide Exchange Factor Son of Sevenless (Sos) Using Site-specific NMR Reporter Signals and Intrinsic Fluorescence.
    Vo U; Vajpai N; Flavell L; Bobby R; Breeze AL; Embrey KJ; Golovanov AP
    J Biol Chem; 2016 Jan; 291(4):1703-1718. PubMed ID: 26565026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular assemblies of the catalytic domain of SOS with KRas and oncogenic mutants.
    Moghadamchargari Z; Shirzadeh M; Liu C; Schrecke S; Packianathan C; Russell DH; Zhao M; Laganowsky A
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polylysine domain of K-ras 4B protein is crucial for malignant transformation.
    Jackson JH; Li JW; Buss JE; Der CJ; Cochrane CG
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12730-4. PubMed ID: 7809111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenylation of Ras proteins is required for efficient hSOS1-promoted guanine nucleotide exchange.
    Porfiri E; Evans T; Chardin P; Hancock JF
    J Biol Chem; 1994 Sep; 269(36):22672-7. PubMed ID: 8077219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B.
    Lu S; Jang H; Nussinov R; Zhang J
    Sci Rep; 2016 Feb; 6():21949. PubMed ID: 26902995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS.
    Yang MH; Laurent G; Bause AS; Spang R; German N; Haigis MC; Haigis KM
    Mol Cancer Res; 2013 Sep; 11(9):1072-7. PubMed ID: 23723075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.
    Mazhab-Jafari MT; Marshall CB; Smith MJ; Gasmi-Seabrook GM; Stathopulos PB; Inagaki F; Kay LE; Neel BG; Ikura M
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6625-30. PubMed ID: 25941399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of RAS oncogenicity by acetylation.
    Yang MH; Nickerson S; Kim ET; Liot C; Laurent G; Spang R; Philips MR; Shan Y; Shaw DE; Bar-Sagi D; Haigis MC; Haigis KM
    Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10843-8. PubMed ID: 22711838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and Mechanistic Insights into the Regulation of the Fundamental Rho Regulator RhoGDIα by Lysine Acetylation.
    Kuhlmann N; Wroblowski S; Knyphausen P; de Boor S; Brenig J; Zienert AY; Meyer-Teschendorf K; Praefcke GJK; Nolte H; Krüger M; Schacherl M; Baumann U; James LC; Chin JW; Lammers M
    J Biol Chem; 2016 Mar; 291(11):5484-5499. PubMed ID: 26719334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR
    Sharma AK; Lee SJ; Rigby AC; Townson SA
    Biomol NMR Assign; 2018 Oct; 12(2):269-272. PubMed ID: 29721757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in flexibility underlie functional differences in the Ras activators son of sevenless and Ras guanine nucleotide releasing factor 1.
    Freedman TS; Sondermann H; Kuchment O; Friedland GD; Kortemme T; Kuriyan J
    Structure; 2009 Jan; 17(1):41-53. PubMed ID: 19141281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into the rearrangement of the switch I region in GTP-bound G12A K-Ras.
    Xu S; Long BN; Boris GH; Chen A; Ni S; Kennedy MA
    Acta Crystallogr D Struct Biol; 2017 Dec; 73(Pt 12):970-984. PubMed ID: 29199977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct dynamics and interaction patterns in H- and K-Ras oncogenic P-loop mutants.
    Sayyed-Ahmad A; Prakash P; Gorfe AA
    Proteins; 2017 Sep; 85(9):1618-1632. PubMed ID: 28498561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics analysis of the structures of ras-guanine nucleotide exchange protein (SOS) bound to wild-type and oncogenic ras-p21. Identification of effector domains of SOS.
    Chen JM; Friedman FK; Hyde MJ; Monaco R; Pincus MR
    J Protein Chem; 1999 Nov; 18(8):867-74. PubMed ID: 10839623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical Characterization of RAS-SOS Complexes by Native Mass Spectrometry.
    Yun S; Scott E; Laganowsky A
    Methods Mol Biol; 2024; 2797():177-193. PubMed ID: 38570460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysine-acetylation as a fundamental regulator of Ran function: Implications for signaling of proteins of the Ras-superfamily.
    Knyphausen P; Kuhlmann N; de Boor S; Lammers M
    Small GTPases; 2015 Oct; 6(4):189-95. PubMed ID: 26507377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT2 and lysine fatty acylation regulate the transforming activity of K-Ras4a.
    Jing H; Zhang X; Wisner SA; Chen X; Spiegelman NA; Linder ME; Lin H
    Elife; 2017 Dec; 6():. PubMed ID: 29239724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.